Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients

Summary

The goal of this prospective randomized double blinded placebo controlled study is to investigate if a single dose of ketamine in addition to standard anesthesia will reduce the risk of delirium in otolaryngeal cancer patients postoperatively. Ketamine's effect on post-operative pain and opioid use will be measured as well. Electroencephalogram (EEG) will be utilized during the surgical procedure to evaluate its potential as a possible predictive device for delirium.

Timeline

Start

2017-03-17

Primary completion

2020-02-24

Completion

2020-04-24

Outcome

Outcome not reported

Stopped: “Halted due to COVID 19; we believe we have adequate data for analysis”

Drugs

Indications